Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

NCT05844436 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

HSV

Interventions

DRUG: Pritelivir

Sponsor

AiCuris Anti-infective Cures AG

Collaborators

[object Object]